91 related articles for article (PubMed ID: 1998596)
1. Acute myeloid leukaemia relapsing following interleukin-2 treatment expresses the alpha chain of the interleukin-2 receptor.
Macdonald D; Jiang YZ; Swirsky D; Vulliamy T; Morilla R; Bungey J; Barrett AJ
Br J Haematol; 1991 Jan; 77(1):43-9. PubMed ID: 1998596
[TBL] [Abstract][Full Text] [Related]
2. Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: a pilot study.
Macdonald D; Jiang YZ; Gordon AA; Mahendra P; Oskam R; Palmer PA; Franks CR; Barrett AJ
Leuk Res; 1990; 14(11-12):967-73. PubMed ID: 2280612
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells.
Nakase K; Kita K; Otsuji A; Anazawa H; Hoshino K; Sekine T; Shirakawa S; Tanaka I; Nasu K; Tsutani H
Br J Haematol; 1992 Mar; 80(3):317-26. PubMed ID: 1581211
[TBL] [Abstract][Full Text] [Related]
4. [The responses of leukemia cells to interleukin-2 in vitro].
Yang Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):188-92. PubMed ID: 10683932
[TBL] [Abstract][Full Text] [Related]
5. Relapse of acute myelogenous leukemia during low dose interleukin-2 (IL-2) therapy. Phenotypic evolution associated with strong expression of the IL-2 receptor alpha chain.
Spiekermann K; O'Brien S; Estey E
Cancer; 1995 Apr; 75(7):1594-7. PubMed ID: 8826915
[TBL] [Abstract][Full Text] [Related]
6. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.
Sander FE; Nilsson M; Rydström A; Aurelius J; Riise RE; Movitz C; Bernson E; Kiffin R; Ståhlberg A; Brune M; Foà R; Hellstrand K; Thorén FB; Martner A
Cancer Immunol Immunother; 2017 Nov; 66(11):1473-1484. PubMed ID: 28721449
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
Paietta E; Van Ness B; Bennett J; Racevskis J; Gucalp R; Cassileth P; Wiernik PH
Br J Haematol; 1992 Oct; 82(2):324-31. PubMed ID: 1419814
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production.
Macdonald D; Gordon AA; Kajitani H; Enokihara H; Barrett AJ
Br J Haematol; 1990 Oct; 76(2):168-73. PubMed ID: 2094320
[TBL] [Abstract][Full Text] [Related]
9. Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group.
Sievers EL; Lange BJ; Sondel PM; Krailo MD; Gan J; Liu-Mares W; Feig SA
J Clin Oncol; 1998 Mar; 16(3):914-9. PubMed ID: 9508173
[TBL] [Abstract][Full Text] [Related]
10. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
Mehta J; Powles R; Kulkarni S; Treleaven J; Singhal S
Bone Marrow Transplant; 1997 Jul; 20(2):129-35. PubMed ID: 9244416
[TBL] [Abstract][Full Text] [Related]
11. Configuration of immunoglobulin and T cell receptor beta and gamma genes in acute myeloid leukaemia: pitfalls in the analysis of 40 cases.
Parreira L; Carvalho C; Moura H; Melo A; Santos P; Guimarães JE; Parreira A
J Clin Pathol; 1992 Mar; 45(3):193-200. PubMed ID: 1372916
[TBL] [Abstract][Full Text] [Related]
12. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
13. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study.
Foa R; Meloni G; Tosti S; Novarino A; Fenu S; Gavosto F; Mandelli F
Br J Haematol; 1991 Apr; 77(4):491-6. PubMed ID: 2025574
[TBL] [Abstract][Full Text] [Related]
15. Lymphoid-associated antigen expression by acute myeloid leukemia.
Launder TM; Bray RA; Stempora L; Chenggis ML; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):185-91. PubMed ID: 8712171
[TBL] [Abstract][Full Text] [Related]
16. [A study on interleukin-2 receptor genes in acute myeloid leukemia cells].
Yang Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):288-92. PubMed ID: 10684036
[TBL] [Abstract][Full Text] [Related]
17. Biological characteristics of CD7 positive acute myelogenous leukaemia.
Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.
Singhal S; Powles R; Kulkarni S; Treleaven J; Saso R; Mehta J
Leuk Lymphoma; 1999 Feb; 32(5-6):505-12. PubMed ID: 10048423
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-5 receptors on acute myeloid leukaemia cells: association with immunophenotype and karyotype.
Nishii K; Kita K; Nadim M; Miwa H; Ohoishi K; Yamaguchi M; Shirakawa S
Br J Haematol; 1995 Sep; 91(1):169-72. PubMed ID: 7577627
[TBL] [Abstract][Full Text] [Related]
20. Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.
Li Y; Valeriote F; Chen B
Exp Hematol; 1996 Feb; 24(2):94-100. PubMed ID: 8641372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
